Andrew A. Hindman - 02 Dec 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, Chief Financial Officer
Signature
Brett A. Grimaud as Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
02 Dec 2021
Net transactions value
$0
Form type
4
Filing time
06 Dec 2021, 18:53:00 UTC
Previous filing
23 Nov 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $0 +340,000 +203% $0.000000 507,258 02 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 2, 2021, the reporting person was granted 340,000 RSUs. 240,000 RSUs are subject to service-based vesting conditions and the remaining 100,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.